Sara Negrelli

Dr. Sara Negrelli


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
FTFrancesca Tamarozzi
Francesca Tamarozzi
MDMonica Degani
Monica Degani
SSSalvatore Scarso
Salvatore Scarso
SNSara Negrelli
Sara Negrelli
STStefano Tais
Stefano Tais
Dora BuonfrateDora Buonfrate
Dora Buonfrate
Background/Objectives: The diagnosis of infection with Strogyloides stercoralis, recently targeted for control by the World Health Organization, (WHO), is challenging. Specific coproparasitological methods (agar plate culture [APC], Baermann sedimentation), recommended by the WHO for public health use, are labor-intensive and require bulky disposable materials as well as experienced microscopists. We explored the sensitivity of an alternative stool culture method using recyclable glass beads, followed by microscopy and PCR in comparison to routine APC and PCR performed on uncultured stool. Methods: We conducted a diagnostic sensitivity study on samples from patients with positive serology for strongyloidiasis who submitted stool specimens to our laboratory between January 2023 and December 2025 for parasitological confirmation. Samples were processed by routine APC and PCR on fresh stool, as well as experimental culture on bead-based plates (BPC), PCR on APC- and BPC-cultured stool, and PCR on stool incubated directly in the collection container. Results: Twenty-six of 110 samples (23.6%) tested positive in at least one technique. Within this subset, the most sensitive techniques were the APC and PCR after APC (both 84.62%); PCR on fresh stool was the least sensitive (42.31%) (p = 0.002). The sensitivity of BPC (65.38%) was lower than that of APC, although not statistically significantly. Comparable sensitivity was observed between microscopy and PCR after APC or BPC. PCR after incubation in the container showed a sensitivity of 57.69%. Agreement ranged from 50 to 84.6%. Conclusions: Alternative culture methods with more field-friendly implementation features could be interesting alternatives to standard methods. Further studies evaluating their performance and applicability in public health and clinical contexts are warranted.

6 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
SRSara Roose
Sara Roose
LSLorenza Sanfilippo
Lorenza Sanfilippo
STStefano Tais
Stefano Tais
SNSara Negrelli
Sara Negrelli
EREleonora Rizzi Eleonora Rizzi
Eleonora Rizzi Eleonora Rizzi
Dora BuonfrateDora Buonfrate
Dora Buonfrate
Background/Objectives: Strongyloides stercoralis is a soil-transmitted helminth that can cause severe disease in immunocompromised individuals. In non-endemic clinical settings, recommended diagnostic strategies rely on serology alone or in combination with a sensitive fecal test, maximizing sensitivity to avoid missed infections. The S. stercoralis VirClia® IgG monotest (Vircell, Spain) is a novel automated chemiluminescent immunoassay (CLIA) that detects IgG antibodies against the recombinant NIE and SsIR antigens. This study evaluated its diagnostic accuracy (sensitivity and specificity) in a non-endemic clinical setting. Methods: In this monocentric retrospective study, 245 serum samples from the Tropica Biobank of a referral centre for parasitic diseases in Italy were analyzed. Samples originated from individuals from Africa (n = 85), America (n = 31), Asia (n = 53), and Europe (n = 76). Diagnostic accuracy was estimated using Bayesian latent class analysis based on a model including five routinely used diagnostic tests. Results: The S. stercoralis VirClia® IgG monotest showed a sensitivity of 95.0% (95% credible interval [CrI]: 90.1–98.2%) and a specificity of 90.8% (95% CrI: 85.1–96.0%) for the tested population. Conclusions: In immunocompetent individuals with a risk of previous exposure to S. stercoralis, the S. stercoralis VirClia® IgG monotest showed high diagnostic accuracy. Its high sensitivity supports current recommendations favouring highly sensitive serological assays for screening and diagnosis in non-endemic clinical settings.